Get started
Author

Stacey M. Plambeck-Suess

Observed name: Stacey Plambeck-Suess
OpenAlex ID: A5073734399
Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2013 · Dominic E. Sanford, Brian A. Belt, et al. · Clinical Cancer Research · 613
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma
2012 · Andrea Wang-Gillam, Stacey Plambeck-Suess, et al. · Investigational New Drugs · 96
Circulating Mesothelin Protein and Cellular Antimesothelin Immunity in Patients with Pancreatic Cancer
2009 · Fabian Mc. Johnston, Marcus C.B. Tan, et al. · Clinical Cancer Research · 81
PDF
A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma
2013 · Dominic E. Sanford, Matthew R. Porembka, et al. · Journal of Cancer Therapy · 31
PDF
A Genetically Encoded Multifunctional TRAIL Trimer Facilitates Cell-Specific Targeting and Tumor Cell Killing
2010 · Dirk Spitzer, Jonathan E. McDunn, et al. · Molecular Cancer Therapeutics · 19
PDF
Supplementary Figure Legends from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
PDF
Supplementary Table 1 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
Supplementary Figure 2 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
PDF
Supplementary Figure 5 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
PDF
Supplementary Figure 1 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
Supplementary Figure 4 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
PDF
Supplementary Methods and Materials from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
PDF
Supplementary Figure 3 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
PDF
Supplementary Figure 6 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
PDF
Supplementary Figure 6 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
Supplementary Figure Legends from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
Supplementary Methods and Materials from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
Supplementary Table 1 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
PDF
Supplementary Figure 5 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
Supplementary Figure 2 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
Supplementary Figure 3 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
Supplementary Figure 4 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
Supplementary Figure 1 from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
PDF
Supplementary Data from A Genetically Encoded Multifunctional TRAIL Trimer Facilitates Cell-Specific Targeting and Tumor Cell Killing
2023 · Dirk Spitzer, Jonathan E. McDunn, et al.
Data from Inflammatory Monocyte Mobilization Decreases Patient Survival in Pancreatic Cancer: A Role for Targeting the CCL2/CCR2 Axis
2023 · Dominic E. Sanford, Brian A. Belt, et al.
Works count: 31
Citation count: 840
H-index: 5
I10-index: 5
Year
Topic
Type